Serum amyloid P and keloid fibrocytes

Wound Repair and Regeneration

Volumn 20, Issue 3, 2012, Pages 277-283

  Naylor, Michelle C ^a   Lazar, David A ^b   Zamora, Irving J ^b   Mushin, Oren P ^b   Yu, Ling ^b   Brissett, Anthony E ^a   Olutoye, Oluyinka O ^b  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SERUM AMYLOID P;

ADULT; ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; KELOID; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; WOUND HEALING; ADOLESCENT; CELL CULTURE; CYTOLOGY; DRUG EFFECT; EXTERNAL EAR; FIBROBLAST; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; PATHOLOGY;

ADOLESCENT; ADULT; CELL DIFFERENTIATION; CELLS, CULTURED; EAR, EXTERNAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLASTS; HUMANS; KELOID; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; SERUM AMYLOID P-COMPONENT; WOUND HEALING; YOUNG ADULT;

EID: 84860606730     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/j.1524-475X.2012.00782.x     Document Type: Article

References (35)

1. Alhady SM, Sivanantharajah K,. Keloids in various races. A review of 175 cases. Plast Reconstr Surg 1969; 44: 564-566.
2. Al-Attar A, Mess S, Thomassen JM, Kauffman CL, Davison SP,. Keloid pathogenesis and treatment. Plast Reconstr Surg 2006; 117: 286-300. (Pubitemid 44391579)
3. Boyce DE, Ciampolini J, Ruge F, Murison MS, Harding KG,. Inflammatory-cell subpopulations in keloid scars. Br J Plast Surg 2001; 54: 511-516.
4. Boyce DE, Jones WD, Ruge F, Harding KG, Moore K,. The role of lymphocytes in human dermal wound healing. Br J Dermatol 2000; 143: 59-65. (Pubitemid 30485245)
5. Fong EP, Bay BH,. Keloids-The sebum hypothesis revisited. Med Hypotheses 2002; 58: 264-269.
6. Haisa M, Okochi H, Grotendorst GR,. Elevated levels of PDGF alpha receptors in keloid fibroblasts contribute to an enhanced response to PDGF. J Invest Dermatol 1994; 103: 560-563. (Pubitemid 24314846)
7. Kischer CW,. The microvessels in hypertrophic scars, keloids and related lesions: a review. J Submicrosc Cytol Pathol 1992; 24: 281-296.
8. Lee TY, Chin GS, Kim WJ, Chau D, Gittes GK, Longaker MT,. Expression of transforming growth factor beta 1, 2, and 3 proteins in keloids. Ann Plast Surg 1999; 43: 179-184. (Pubitemid 29380019)
9. McCauley RL, Chopra V, Li YY, Herndon DN, Robson MC,. Altered cytokine production in black patients with keloids. J Clin Immunol 1992; 12: 300-308.
10. Shih B, Garside E, McGrouther DA, Bayat A,. Molecular dissection of abnormal wound healing processes resulting in keloid disease. Wound Rep Reg 2010; 18: 139-153.
11. Medina A, Ghahary A,. Fibrocytes can be reprogrammed to promote tissue remodeling capacity of dermal fibroblasts. Mol Cell Biochem 2010; 344: 11-21.
12. Babu M, Diegelmann R, Oliver N,. Fibronectin is overproduced by keloid fibroblasts during abnormal wound healing. Mol Cell Biol 1989; 9: 1642-1650. (Pubitemid 19095205)
13. Friedman DW, Boyd CD, Mackenzie JW, Norton P, Olson RM, Deak SB,. Regulation of collagen gene expression in keloids and hypertrophic scars. J Surg Res 1993; 55: 214-222. (Pubitemid 23335800)
14. Amadeu TP, Braune AS, Porto LC, Desmouliere A, Costa AM,. Fibrillin-1 and elastin are differentially expressed in hypertrophic scars and keloids. Wound Rep Reg 2004; 12: 169-174. (Pubitemid 38520683)
15. Haudek SB, Xia Y, Huebener P, Lee JM, Carlson S, Crawford JR, Pilling D, Gomer RH, Trial J, Frangogiannis NG, Entman ML,. Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice. Proc Natl Acad Sci U S A 2006; 103: 18284-18289. (Pubitemid 44871650)
16. Pilling D, Buckley CD, Salmon M, Gomer RH,. Inhibition of fibrocyte differentiation by serum amyloid P. J Immunol 2003; 171: 5537-5546. (Pubitemid 37432844)
17. Pilling D, Roife D, Wang M, Ronkainen SD, Crawford JR, Travis EL, Gomer RH,. Reduction of bleomycin-induced pulmonary fibrosis by serum amyloid P. J Immunol 2007; 179: 4035-4044.
18. Bucala R, Spiegel LA, Chesney J, Hogan M, Cerami A,. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1994; 1: 71-81.
19. Bellini A, Mattoli S,. The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses. Lab Invest 2007; 87: 858-870. (Pubitemid 47267815)
20. Chesney J, Metz C, Stavitsky AB, Bacher M, Bucala R,. Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes. J Immunol 1998; 160: 419-425. (Pubitemid 28116757)
21. Keeley EC, Mehrad B, Strieter RM,. Fibrocytes: bringing new insights into mechanisms of inflammation and fibrosis. Int J Biochem Cell Biol 2010; 42: 535-542.
22. Chesney J, Bacher M, Bender A, Bucala R,. The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ. Proc Natl Acad Sci U S A 1997; 94: 6307-6312. (Pubitemid 27270680)
23. Quan TE, Cowper S, Wu SP, Bockenstedt LK, Bucala R,. Circulating fibrocytes: collagen-secreting cells of the peripheral blood. Int J Biochem Cell Biol 2004; 36: 598-606. (Pubitemid 38316817)
24. Yang L, Scott PG, Dodd C, Medina A, Jiao H, Shankowsky HA, Ghahary A, Tredget EE,. Identification of fibrocytes in postburn hypertrophic scar. Wound Rep Reg 2005; 13: 398-404. (Pubitemid 41060421)
25. Wang JF, Jiao H, Stewart TL, Shankowsky HA, Scott PG, Tredget EE,. Fibrocytes from burn patients regulate the activities of fibroblasts. Wound Rep Reg 2007; 15: 113-121. (Pubitemid 46146670)
26. Hartlapp I, Abe R, Saeed RW, Peng T, Voelter W, Bucala R, Metz CN,. Fibrocytes induce an angiogenic phenotype in cultured endothelial cells and promote angiogenesis in vivo. FASEB J 2001; 15: 2215-2224. (Pubitemid 32927939)
27. Abe R, Donnelly SC, Peng T, Bucala R, Metz CN,. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 2001; 166: 7556-7562. (Pubitemid 32525636)
28. Naik-Mathuria B, Pilling D, Crawford JR, Gay AN, Smith CW, Gomer RH, Olutoye OO,. Serum amyloid P inhibits dermal wound healing. Wound Rep Reg 2008; 16: 266-273. (Pubitemid 351342135)
29. Nelson SR, Tennent GA, Sethi D, Gower PE, Ballardie FW, Amatayakul-Chantler S, Pepys MB,. Serum amyloid P component in chronic renal failure and dialysis. Clin Chim Acta 1991; 200: 191-199.
30. Char F,. Ehlers-Danlos syndrome. Birth Defects Orig Artic Ser 1971; 7: 300-302.
31. Siraganian PA, Rubinstein JH, Miller RW,. Keloids and neoplasms in the Rubinstein-Taybi syndrome. Med Pediatr Oncol 1989; 17: 485-491. (Pubitemid 20018260)
32. Marneros AG, Norris JE, Watanabe S, Reichenberger E, Olsen BR,. Genome scans provide evidence for keloid susceptibility loci on chromosomes 2q23 and 7p11. J Invest Dermatol 2004; 122: 1126-1132. (Pubitemid 38651086)
33. Yan X, Gao JH, Chen Y, Song M, Liu XJ,. Preliminary linkage analysis and mapping of keloid susceptibility locus in a Chinese pedigree. Zhonghua Zheng Xing Wai Ke Za Zhi 2007; 23: 32-35.
34. Brown JJ, Ollier WE, Arscott G, Bayat A,. Association of HLA-DRB1* and keloid disease in an Afro-Caribbean population. Clin Exp Dermatol 2010; 35: 305-310.
35. Lu WS, Wang JF, Yang S, Xiao FL, Quan C, Cheng H, Wang PG, Zhang AP, Cai LQ, Zhang XJ,. Association of HLA-DQA1 and DQB1 alleles with keloids in Chinese Hans. J Dermatol Sci 2008; 52: 108-117.